Functional analysis of a transrepressor domain in the hepatitis C virus core protein

Virus Research

Volumn 59, Issue 2, 1999, Pages 211-217

  Ray, Ratna B ^a,b   Ghosh, Asish K ^a   Meyer, Keith ^b   Ray, Ranjit ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine   (United States)

Author keywords

Hepatitis C virus; Repressor domain; Transcriptional regulation

Indexed keywords

CORE PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE FUSION; HEPATITIS C; HEPATITIS C VIRUS; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; REPRESSOR GENE; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COS CELLS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION; HEPACIVIRUS; HUMANS; MICE; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS; HERPES; HUMAN HERPESVIRUS 4; SIMPLEXVIRUS;

EID: 0033040314     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00138-5     Document Type: Article

References (25)

1. Chang J., Yang S., Cho Y., Hwang S.B., Hahn Y.S., Sung Y.C. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol. 72:1998;3060-3065.
2. Cowell I.G. Repression versus activation in the control of gene transcription. Trends Biochem. Sci. 19:1994;38-42.
3. Goodrich J.A., Tijan R. TBP-TAF complexes: selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 6:1994;403-409.
4. Guarente L. Transcriptional coactivators in yeast and beyond. Trends Biochem. Sci. 20:1995;517-521.
5. Hanna-Rose W., Hansen U. Active repression mechanisms of eukaryotic transcription repressors. Trends Genet. 12:1996;229-234.
6. Herschbach B., Johnson A.D. Transcriptional repression in eukaryotes. Ann. Rev. Cell Biol. 9:1993;479-509.
7. Johnson A.D. The price of repression. Cell. 81:1995;655-658.
8. Kim D.W., Suzuki R., Harada T., Saito I., Miyamura T. Trans-suppression of gene expression by hepatitis C virus core protein. Jpn. J. Med. Sci. Biol. 47:1994;211-220.
9. Kolykhalov A.A., Agapov E.V., Bright K.J., Mihalik K., Feinstone S.M., Rice C.M. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science. 277:1997;570-574.
10. Marshall D., Sample C. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:1995;3624-3630.
11. Ptashne M., Gan A. Transcription activation by recruitment. Nature. 386:1997;569-577.
12. Ray R.B., Lagging L.M., Meyer K., Steele R., Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 7:1995;209-220.
13. Ray R.B., Lagging L.M., Meyer K., Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:1996;4438-4443.
14. Ray R.B., Steele R., Meyer K., Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272:1997;10983-10986.
15. Ray R.B., Steele R., Meyer K., Ray R. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene. 208:1998;331-336.
16. Roberts S.G.E., Green M.R. Transcription dichotomous regulators. Nature. 375:1995;105-106.
17. Sadowski I., Ptashne M. A vactor for expressing GAL4 (1-147) fusions in mammalian cells. Nucleic Acids Res. 17:1989;7539.
18. Sadowski I., Bell B., Broad P., Hollis M. Gal4 fusion vectors for expression in yeast or mammalian cells. Gene. 118:1992;137-141.
19. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6547-6549.
20. Santolini E., Migliaccio G., La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68:1994;3631-3641.
21. Shih C.M., Chen C.M., Chen S.Y., Lee Y.H. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 69:1995;1160-1171.
22. Srinivas R.V., Ray R.B., Meyer K., Ray R. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res. 45:1996;87-92.
23. Yamamoto H., Lampier M.S., Fujita T., Taniguchi T., Harada H. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Oncogene. 9:1994;1423-1428.
24. Yanagi M., Puercell R.H., Emerson S.U., Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8738-8743.
25. Yasui K., Wakita T., Tsukiyama-Kohara T., Funahashi S.-I., Ichikawa M., Kajita T., Moradpour D., Wands J.R., Kohara M. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72:1998;6048-6055.